Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Technique Allows Noninvasive Tracking, Imaging of Stem Cells in the Brain

By LabMedica International staff writers
Posted on 05 Apr 2011
A new technique using quantum dot technology generated through nanotechnology is a promising new tool for monitoring the effects of stem cell therapies for stroke and other types of brain damage. More...


The study's findings were published in the April 2011 issue of the journal Neurosurgery, the journal of the Congress of Neurological Surgeons. The researchers reported the successful use of near-infrared fluorescence labeling to track the behavior of injected stem cells in brain-injured rats. "The results open up new opportunities to develop noninvasive near-infrared fluorescence imaging...to track bone marrow stem cells transplanted into the human brain,” wrote Dr. Taku Sugiyama and colleagues of Hokkaido University Graduate School of Medicine (Sapporo, Japan).

The researchers utilized bone marrow stem cells to treat induced brain injuries, similar to stroke, in rats. Before injection, the stem cells were labeled with quantum dots, a biocompatible, fluorescent semiconductor created using nanotechnology.

Other fluorescence techniques used to label stem cells have an important limitation their comparatively short wavelengths do not easily penetrate through bone and skin. The quantum dots emit near infrared light, with much longer wavelengths that can easily penetrate tissues. This allowed the researchers to monitor the behavior of stem cells within the brain after transplantation using a computer-assisted, three-dimensional (3D) imaging system.

Using this technology, Dr. Sugiyama and colleagues were able to detect near-infrared fluorescence from the stem cells as they moved to and incorporated themselves into the area around the injured area of the brain. Reflecting the stem cells' behavior, the fluorescence increased gradually, peaking at four weeks after injection. The fluorescence remained detectable for up to eight weeks. The results were validated by direct examination of the brains.

Stem cell transplantation is a potentially beneficial treatment for stroke and other central nervous system disorders. The use of stem cells developed from the patient's own bone marrow is a particularly promising approach. For example, a study in the March 2011 issue of the journal Neurosurgery reported that bone marrow stem cell transplantation was a "logistically feasible and safe” approach to treatment of severe traumatic brain injury in children.

However, some sort of imaging system is needed to track the activity of stem cells as they travel to the injured area and develop into new brain cells. "Such techniques would be crucial to validate the therapeutic benefits of bone marrow stem cell transplantation for central nervous system disorders,” Dr. Sugiyama and coauthors wrote in their article.

Near-infrared fluorescence labeling using quantum dots appears to provide a noninvasive technique for monitoring the effects of stem cell transplantation in the rat brain. Additional studies will be needed to see if similar techniques can be developed and used in humans, according to the researchers. If so, this technology would be an important part of experimental stem cell therapies to enhance functional recovery of the brain after stroke or other types of injury.

Related Links:

Hokkaido University Graduate School of Medicine



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.